Abstract:Here, an injectable magnetic hydrogel nanosystem for the dual‐purpose magnetothermal and anti‐inflammatory treatment of endometriosis is well designed. Upon magnetic activation, the hydrogel containing Fe3O4 nanoparticles can induce a localized hyperthermic response, effectively destroying endometriotic cells and facilitating the release of anti‐inflammatory peptide. Consequently, this work offers a promising non‐invasive treatment modality for synergistical magnetothermal and anti‐inflammatory treatment of endometriosis. Endometriosis is a prevalent gynecological condition characterized by chronic pelvic pain, dysmenorrhea, and infertility, affecting ≈176 million women of reproductive age worldwide. Current treatments, including pharmacological and surgical interventions, are often associated with significant side effects and high recurrence rates. Consequently, there is an urgent need for innovative and safer therapeutic approaches. In this study, an injectable magnetic hydrogel nanosystem is developed designed for the dual‐purpose magnetothermal and anti‐inflammatory treatment of endometriosis. This hydrogel incorporates Fe3O4 nanoparticles alongside an anti‐inflammatory peptide. Upon magnetic activation, the Fe3O4 nanoparticles induce a localized hyperthermic response, raising the temperature of endometriotic lesions to 63.3 °C, effectively destroying endometriotic cells. Concurrently, the thermally responsive hydrogel facilitates the controlled release of the anti‐inflammatory peptide, thus modulating the inflammatory milieu. The biocompatibility and complete in vivo degradability of the hydrogel further enhance its therapeutic potential. The in vivo studies demonstrated that this injectable magnetic hydrogel system achieved a 90% reduction in the volume of endometriotic lesions and significantly decreased inflammatory markers, offering a promising non‐invasive treatment modality for endometriosis. By integrating precise lesion ablation with the modulation of the inflammatory microenvironment, this system represents a novel approach to the clinical management of endometriosis.

Hyaluronic Acid Reagent Functional Chitosan-Pei Conjugate with AQP2-siRNA Suppressed Endometriotic Lesion Formation.

Hyaluronic Acid-Modified Nanoplatforms As a Vector for Targeted Delivery of Autophagy-Related Gene to the Endometriotic Lesions in Mice

Gene therapy of endometriosis introduced by polymeric micelles with glycolipid-like structure.

Effect of A-317491 Delivered by Glycolipid-Like Polymer Micelles on Endometriosis Pain

Specific Photothermal Ablation Therapy of Endometriosis by Targeting Delivery of Gold Nanospheres.

iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis

A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.

Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosis and Cancer In Vitro Models

Inhibitory effect of AQP1 silencing on adhesion and angiogenesis in ectopic endometrial cells of mice with endometriosis through activating the Wnt signaling pathway

Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer

Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal/endocrine synergistic endometriosis therapy

Targeted Sirna Delivery by Anti-Her2 Antibody-Modified Nanoparticles of Mpeg-Chitosan Diblock Copolymer

A Multifunctional Nanoparticle for Efferocytosis and Pro-Resolving-mediated Endometriosis Therapy

Novel Chitosan Derivatives with Reversible Cationization and Hydrophobicization for Tumor Cytoplasm-Specific Burst Co-delivery of Sirna and Chemotherapeutics

Injectable Magnetic Hydrogel Incorporated with Anti‐Inflammatory Peptide for Efficient Magnetothermal Treatment of Endometriosis

Co-delivery of siRNA and docetaxel by hyaluronic acid modified redox-sensitive disulfide-crosslinked nanoparticles

Low-weight Polyethylenimine Cross-Linked 2-Hydroxypopyl-β-cyclodextrin and Folic Acid As an Efficient and Nontoxic Sirna Carrier for Gene Silencing and Tumor Inhibition by VEGF Sirna

Effect of Recombinant Human Endostatin on Endometriosis in Mice

Microfluidics-derived hierarchical microparticles for the delivery of dienogest for localized endometriosis therapy

The Enhanced Antitumor Effects of Biodegradable Cationic Heparin-Polyethyleneimine Nanogels Delivering HSulf-1 Gene Combined with Cisplatin on Ovarian Cancer

A Dopamine-Modified Hyaluronic Acid-Based Mucus Carrying Phytoestrogen and Urinary Exosome for Thin Endometrium Repair